Identification of JAK/STAT signalling components by genome-wide RNA interference

Patrick Müller, David Kuttenkeuler, Viola Gesellchen, Martin P. Zeidler () and Michael Boutros ()
Additional contact information
Patrick Müller: Max Planck Institute for Biophysical Chemistry
David Kuttenkeuler: Boveri-Group Signaling and Functional Genomics, German Cancer Research Center
Viola Gesellchen: Boveri-Group Signaling and Functional Genomics, German Cancer Research Center
Martin P. Zeidler: Max Planck Institute for Biophysical Chemistry
Michael Boutros: Boveri-Group Signaling and Functional Genomics, German Cancer Research Center

Nature, 2005, vol. 436, issue 7052, 871-875

Abstract: Abstract Signalling pathways mediating the transduction of information between cells are essential for development, cellular differentiation and homeostasis1. Their dysregulation is also frequently associated with human malignancies. The Janus tyrosine kinase/signal transducer and activator of transcription (JAK/STAT) pathway represents one such signalling cascade whose evolutionarily conserved roles include cell proliferation and haematopoiesis2. Here we describe a systematic genome-wide survey for genes required for JAK/STAT pathway activity. Analysis of 20,026 RNA interference (RNAi)-induced phenotypes in cultured Drosophila melanogaster haemocyte-like cells identified interacting genes encoding 4 known and 86 previously uncharacterized proteins. Subsequently, cell-based epistasis experiments were used to classify these proteins on the basis of their interaction with known components of the signalling cascade. In addition to multiple human disease gene homologues, we have found the tyrosine phosphatase Ptp61F and the Drosophila homologue of BRWD3, a bromo-domain-containing protein disrupted in leukaemia3. Moreover, in vivo analysis demonstrates that disrupted dBRWD3 and overexpressed Ptp61F function as suppressors of leukaemia-like blood cell tumours. This screen represents a comprehensive identification of novel loci required for JAK/STAT signalling and provides molecular insights into an important pathway relevant for human cancer. Human homologues of identified pathway modifiers may constitute targets for therapeutic interventions.

Date: 2005
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/nature03869 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:436:y:2005:i:7052:d:10.1038_nature03869

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/nature03869

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().